Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T17:03:57.480Z.
Calculation as of: 2026-10-06T17:03:57.480Z.
Quote observation: 2026-10-06T17:00:52.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 24a0b8a5defa6360a8df5348432e42fec2fdf5a1d44ff9a0d63a76d612d48360
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$1.09B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.08B
EV/EBIT Ratio
37.13x
TTM Avg
43.03x
3Y Avg
33.26x
5Y Avg
35.95x
Market Cap
$1.11B
EV/EBIT Ratio
28.39x
TTM Avg
30.09x
3Y Avg
62.24x
5Y Avg
80.49x
Market Cap
$1.13B
EV/EBIT Ratio
235.56x
TTM Avg
98.35x
3Y Avg
222.12x
5Y Avg
246.60x
Market Cap
$1.13B
EV/EBIT Ratio
13.94x
TTM Avg
11.45x
3Y Avg
12.41x
5Y Avg
16.01x
Market Cap
$1.13B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Replimune Group, Inc. (REPL) | $1.10B | N/A | N/A | N/A | N/A |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | N/A | N/A | N/A | N/A |
| IRadimed Corporation (IRMD)vs › | $1.08B | 37.13x | 43.03x | 33.26x | 35.95x |
| STAAR Surgical Company (STAA)vs › | $1.11B | 28.39x | 30.09x | 62.24x | 80.49x |
| OPKO Health, Inc. (OPK)vs › | $1.12B | N/A | 39.17x | 40.90x | 40.90x |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 235.56x | 98.35x | 222.12x | 246.60x |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 13.94x | 11.45x | 12.41x | 16.01x |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | N/A | N/A | N/A | N/A |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | 4.37x | 22.68x | 78.76x | 55.76x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
